Vericel Corp·4

Jun 22, 4:05 PM ET

Flynn Sean C. 4

4 · Vericel Corp · Filed Jun 22, 2026

Research Summary

AI-generated summary of this filing

Updated

Vericel (VCEL) CLO Sean Flynn Exercises Options, Sells 15,000 Shares

What Happened
Sean C. Flynn, Chief Legal Officer of Vericel Corp (VCEL), exercised derivative awards and sold 15,000 shares on June 18, 2026. The filing shows an exercise/conversion of 15,000 shares at $16.25 per share (cost $243,750) and a sale of 15,000 shares in the open market at $40.21 per share (gross proceeds $603,150). The Form 4 also records a separate derivative acquisition of 15,000 shares at $0.00 per share.

Key Details

  • Transaction date: June 18, 2026. Form filed: June 22, 2026.
  • Exercises recorded: 15,000 shares @ $16.25 (acquired; $243,750); 15,000 shares @ $0.00 (acquired; listed as derivative).
  • Sale recorded: 15,000 shares sold @ $40.21 — gross proceeds $603,150.
  • Shares owned after transaction: not specified in the data provided on this summary.
  • Footnotes from the filing:
    • F1: Some shares include purchases under the Issuer's 2015 Employee Stock Purchase Plan (ESPP), exempt under Rule 16b-3(d)/(c).
    • F2: The sale was effected automatically under a Rule 10b5-1 trading plan adopted by Flynn on December 2, 2025.
    • F3: The referenced options represent the right to purchase 150,000 shares and vested beginning Nov 4, 2020 (25% then, remainder quarterly over three years).
  • Filing timeliness: filing and transaction dates are listed above; the form does not indicate additional timing notes beyond those dates.

Context
Because the exercises and the sale occurred the same day, this appears to be a cashless-style transaction where exercised shares were sold immediately. The open-market sale was executed under an automatic 10b5-1 plan, which is a pre-established trading arrangement and commonly used by insiders to sell shares without active timing decisions. The filing is factual and does not indicate motive; purchases (notably from ESPP or option exercises) and rule-based sales are common insider transactions.

Insider Transaction Report

Form 4
Period: 2026-06-18
Flynn Sean C.
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-18$16.25/sh+15,000$243,75016,647 total
  • Sale

    Common Stock

    [F2][F1]
    2026-06-18$40.21/sh15,000$603,1501,647 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F3]
    2026-06-18+15,00070,000 total
    Exercise: $16.25Exp: 2029-11-04Common Stock (15,000 underlying)
Footnotes (3)
  • [F1]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  • [F3]These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Signature
/s/ Sean Flynn|2026-06-22

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4